Sold 697 shares
of Common Stock
at $329.82 per share
(Direct)
Date: 2026-05-02 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 81,707.00 | transaction_form_type: 4
Sold 641 shares
of Common Stock
at $329.82 per share
(Direct)
Date: 2026-05-02 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 81,066.00 | transaction_form_type: 4 | Footnotes: F1
Holds 0 shares
of Common Stock
(Direct)
Date: 2026-05-02 |
Code: H
| nature_of_ownership: 401K Plan | shares_owned_after: 909.99 | Footnotes: F2
Footnotes:
F1: These shares include 414 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F2: These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
🔍 Santos Esteban (Executive)
Company: AMGEN INC (AMGN)
Report Date: 2026-05-02
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-05-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 81,707.00 | transaction_form_type: 4
Date: 2026-05-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 81,066.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-05-02 | Code: H | nature_of_ownership: 401K Plan | shares_owned_after: 909.99 | Footnotes: F2
Footnotes: